Pharmafile Logo

Peter Impey

- PMLiVE

AbbVie, Roche get FDA OK for broader use of Venclexta

The drug is tipped to become a $2.5bn product by 2024

Patient outcomes in practice: delivering value that transforms lives

In this month’s PME, Lucid CEO and co-founder, Dennis O’Brien, and Managing Director, Louise Verrall, discuss ‘Patient outcomes in practice: delivering value that transforms lives’. In response to the increasing...

Lucid Group Communications Limited

Reaching the new influencers

With payers looking increasingly to real-world data, and to differentiation beyond this data through outcomes commitment and the provision of beyond the pill services, there’s never been a better time...

EU flag

UK pharma cheers EU science announcement

UK won't be excluded from Horizon research collaboration

Introducing eConnext™: The Next Generation of Online Conference Engagement

TORONTO, CANADA, June 8, 2018— Six Degrees Medical (SDM) announces the launch of eConnext™. eConnext™ combines SDM’s medical writing and pharmaceutical industry content development experience with state-of-the-art virtual meeting platforms...

Six Degrees Medical Consulting

- PMLiVE

Roche’s MabThera ends drug drought for serious skin disease

As biosimilars seize market share, Roche finds ways to extend blockbuster's revenues

- PMLiVE

If you’re going global, go local and go early

A brief arrives in your inbox. You have been asked to develop an integrated communications plan for a global healthcare company. A plan that builds disease awareness, establishes unmet needs,...

- PMLiVE

Merck’s Brexit contingency plan? Stockpile medicines

As UK's Brexit plans remain in disarray, big pharma is making contingency plans

- PMLiVE

Aptar Pharma advances digital offerings

Partners up with digital therapeutics company Propeller Health

- PMLiVE

Communications in a mobile age

mHealth: when will pharma catch up?

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links